Clinical Trials Directory

Trials / Completed

CompletedNCT03051347

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments Sub-Study: Clinically Relevant Endpoints in Atopic Dermatitis in Children (CREAD-C)--Funded by Regeneron

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
943 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
0 Years – 17 Years
Healthy volunteers
Not accepted

Summary

This is designated to validate patient-reported outcomes (PRO) measures in itch-specific pediatric skin conditions, such as atopic dermatitis, and examine the ability of a modified stigma instrument to assess the severity and type of stigma experienced in atopic dermatitis and other potentially stigmatizing conditions.

Detailed description

This study involves a series of research and development projects targeted at two of the most common chronic diseases affecting children: asthma and atopic dermatitis (AD, or eczema). The Investigators propose to directly validate patient-reported outcomes (PRO) measures in a large cohort of itch-specific pediatric skin conditions, with a primary focus on AD. The Investigators propose to examine the ability of PROMIS (Patient-Reported Outcomes Measurement Information Systems) instruments to detect meaningful and clinically significant change in disease status, as well as to create a pediatric itch item pool and PRO model for signs and symptoms of skin disease. The Investigators will also examine the ability of a modified Neuro-QOL stigma instrument to assess the severity and type of stigma experienced in AD and across various dermatologic or other potentially stigmatizing conditions. Lurie Children's Hospital will only be involved in the AD and stigma portions of this project

Conditions

Interventions

TypeNameDescription
OTHERItch Questionnaire and Interview
OTHERStigma Questionnaire and Interview
OTHERCognitive Interview and PROMIS Itch Questionnaire

Timeline

Start date
2016-09-01
Primary completion
2020-02-09
Completion
2020-06-30
First posted
2017-02-13
Last updated
2020-10-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03051347. Inclusion in this directory is not an endorsement.